These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

409 related articles for article (PubMed ID: 12579258)

  • 21. Detection of K-ras mutations in mucinous pancreatic duct hyperplasia from a patient with a family history of pancreatic carcinoma.
    DiGiuseppe JA; Hruban RH; Offerhaus GJ; Clement MJ; van den Berg FM; Cameron JL; van Mansfeld AD
    Am J Pathol; 1994 May; 144(5):889-95. PubMed ID: 8178941
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mixed ductal-endocrine carcinoma derived from intraductal papillary mucinous neoplasm (IPMN) of the pancreas identified by human telomerase reverse transcriptase (hTERT) expression.
    Hashimoto Y; Murakami Y; Uemura K; Hayashidani Y; Sudo T; Ohge H; Sueda T; Shimamoto F; Hiyama E
    J Surg Oncol; 2008 Apr; 97(5):469-75. PubMed ID: 18161862
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relationship between K-ras mutation and the expression of p21WAF1/CIP1 and p53 in chronic pancreatitis and pancreatic adenocarcinoma.
    Hermanová M; Lukás Z; Kroupová I; Kleibl Z; Novotný J; Nenutil R; Pazourková M; Brázdil J; Kren L; Díte P
    Neoplasma; 2003; 50(5):319-25. PubMed ID: 14628083
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genetic diagnosis of pancreatic cancer.
    Mizumoto K; Tanaka M
    J Hepatobiliary Pancreat Surg; 2002; 9(1):39-44. PubMed ID: 12021896
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Invasive cancer and survival of intraductal papillary mucinous tumors of the pancreas.
    Raimondo M; Tachibana I; Urrutia R; Burgart LJ; DiMagno EP
    Am J Gastroenterol; 2002 Oct; 97(10):2553-8. PubMed ID: 12385438
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of laminin-5-gamma-2 chain in intraductal papillary-mucinous and invasive ductal tumors of the pancreas.
    Fukushima N; Sakamoto M; Hirohashi S
    Mod Pathol; 2001 May; 14(5):404-9. PubMed ID: 11353049
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diagnosis of pancreatic cancer by detecting telomerase activity in pancreatic juice: comparison with K-ras mutations.
    Uehara H; Nakaizumi A; Tatsuta M; Baba M; Takenaka A; Uedo N; Sakai N; Yano H; Iishi H; Ohigashi H; Ishikawa O; Okada S; Kakizoe T
    Am J Gastroenterol; 1999 Sep; 94(9):2513-8. PubMed ID: 10484017
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A highly sensitive and quantitative telomerase activity assay with pancreatic juice is useful for diagnosis of pancreatic carcinoma without problems due to polymerase chain reaction inhibitors: analysis of 100 samples of pancreatic juice from consecutive patients.
    Ohuchida K; Mizumoto K; Ishikawa N; Sato N; Nagai E; Yamaguchi K; Takaishi H; Ide T; Tanaka M
    Cancer; 2004 Nov; 101(10):2309-17. PubMed ID: 15476274
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clonality and field cancerization in intraductal papillary-mucinous tumors of the pancreas.
    Izawa T; Obara T; Tanno S; Mizukami Y; Yanagawa N; Kohgo Y
    Cancer; 2001 Oct; 92(7):1807-17. PubMed ID: 11745253
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genetic alterations in adenoma-carcinoma sequencing of intraductal papillary-mucinous neoplasm of the pancreas.
    Nakata B; Yashiro M; Nishioka N; Aya M; Yamada S; Takenaka C; Ohira M; Ishikawa T; Nishino H; Wakasa K; Hirakawa K
    Int J Oncol; 2002 Nov; 21(5):1067-72. PubMed ID: 12370756
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of K-ras gene mutations in association with mucinous hypersecretion in intraductal papillary-mucinous neoplasms.
    Kobayashi N; Inamori M; Fujita K; Fujisawa T; Fujisawa N; Takahashi H; Yoneda M; Abe Y; Kawamura H; Shimamura T; Kirikoshi H; Kubota K; Sakaguchi T; Saito S; Saubermann LJ; Nakajima A
    J Hepatobiliary Pancreat Surg; 2008; 15(2):169-77. PubMed ID: 18392710
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Single-pattern convergence of K-ras mutation correlates with surgical indication of intraductal papillary mucinous neoplasms.
    Mizuno O; Kawamoto H; Yamamoto N; Horiguchi S; Tsutsumi K; Fujii M; Kato H; Hirao K; Kurihara N; Ishida E; Ogawa T; Okada H; Yamamoto K
    Pancreas; 2010 Jul; 39(5):617-21. PubMed ID: 20173673
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of p21ras in pancreatic neoplasia and chronic pancreatitis.
    Mulligan NJ; Yang S; Andry C; Klein M; O'Brien MJ
    Hum Pathol; 1999 Jun; 30(6):602-10. PubMed ID: 10374765
    [TBL] [Abstract][Full Text] [Related]  

  • 34. P53 expression, p53 and Ha-ras mutation and telomerase activation during nitrosamine-mediated hamster pouch carcinogenesis.
    Chang KW; Sarraj S; Lin SC; Tsai PI; Solt D
    Carcinogenesis; 2000 Jul; 21(7):1441-51. PubMed ID: 10874024
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Detection of human telomerase reverse transcriptase (hTERT) expression in tissue and pancreatic juice from pancreatic cancer.
    Hashimoto Y; Murakami Y; Uemura K; Hayashidani Y; Sudo T; Ohge H; Fukuda E; Sueda T; Hiyama E
    Surgery; 2008 Jan; 143(1):113-25. PubMed ID: 18154939
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adenosquamous carcinoma of the pancreas: preoperative diagnosis and molecular alterations.
    Murakami Y; Yokoyama T; Yokoyama Y; Kanehiro T; Uemura K; Sasaki M; Morifuji M; Sueda T
    J Gastroenterol; 2003; 38(12):1171-5. PubMed ID: 14714256
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Problems in histological diagnosis of intraductal papillary-mucinous tumor (IPMT).
    Nagasaka T; Nakashima N
    Hepatogastroenterology; 2001; 48(40):972-6. PubMed ID: 11490851
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intraductal papillary mucinous tumors of the pancreas.
    Schmitz-Winnenthal FH; Z'graggen K; Volk C; Schmied BM; Büchler MW
    Curr Gastroenterol Rep; 2003 Apr; 5(2):133-40. PubMed ID: 12631453
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Morphologic, morphometric and immunohistochemical studies on pancreatic intraductal hyperplasia and infiltrating carcinoma].
    Tomaszewska R
    Folia Med Cracov; 1999; 40(1-2):101-41. PubMed ID: 10909469
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinicopathological features of malignant intraductal papillary mucinous tumors of the pancreas: the differential diagnosis from benign entities.
    Kawai M; Uchiyama K; Tani M; Onishi H; Kinoshita H; Ueno M; Hama T; Yamaue H
    Arch Surg; 2004 Feb; 139(2):188-92. PubMed ID: 14769579
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.